2020
DOI: 10.34067/kid.0004282020
|View full text |Cite
|
Sign up to set email alerts
|

Characteristics, Outcomes and 60-Day Hospital Mortality of ICU Patients with COVID-19 and Acute Kidney Injury

Abstract: BackgroundAKI has been reported in patients with COVID-19 pneumonia and it is associated with higher mortality. The aim of our study is to describe characteristics, outcomes, and 60-day hospital mortality of patients with COVID-19 pneumonia and AKI in the intensive care unit (ICU).MethodsWe conducted a retrospective study in which all adult patients with confirmed COVID-19 who were admitted to ICUs of Montefiore Medical Center and developing AKI were included. The study period ranged from March 10 to April 11,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
16
1
3

Year Published

2020
2020
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 24 publications
(22 citation statements)
references
References 13 publications
2
16
1
3
Order By: Relevance
“…Among our all AKI cases, the mortality for the AKI groups, Stage I, Stage II and the RRT group are 25, 25 and 27% respectively. This is lower than the 56% national mortality in patients receiving RRT reported in the UK ICNARC outcome dataset and from other international studies [ 3 , 4 , 18 ]. Patients in our RRT cohort had similar age and acute severity indices (APACHE II of 21, PaO 2 /FiO 2 15.1 kPa or 113 mmHg) with higher mechanical ventilation rate (100%) and 92% had vasoactive agents as advanced cardiovascular support suggesting this group is comparable to the ICNARC dataset [ 4 ].…”
Section: Discussioncontrasting
confidence: 53%
See 1 more Smart Citation
“…Among our all AKI cases, the mortality for the AKI groups, Stage I, Stage II and the RRT group are 25, 25 and 27% respectively. This is lower than the 56% national mortality in patients receiving RRT reported in the UK ICNARC outcome dataset and from other international studies [ 3 , 4 , 18 ]. Patients in our RRT cohort had similar age and acute severity indices (APACHE II of 21, PaO 2 /FiO 2 15.1 kPa or 113 mmHg) with higher mechanical ventilation rate (100%) and 92% had vasoactive agents as advanced cardiovascular support suggesting this group is comparable to the ICNARC dataset [ 4 ].…”
Section: Discussioncontrasting
confidence: 53%
“…Our renal replacement rate is also comparable to the reports from larger cohorts with a rate of 20–31% [ 3 , 4 ]. However, in studies of mostly invasively ventilated critically ill COVID 19 patients, the incidence of AKI was reported to be as high as 75% with an RRT rate of 17.7–51% [ 10 , 18 , 19 ]. In contrast, our cohort was inclusive of patients with noninvasive ventilation, which may account for the difference in AKI prevalence, RRT rate and mortality.…”
Section: Discussionmentioning
confidence: 99%
“…Bei 60–90 % dieser Patient*innen kommt es zum AKI, bei 20–37 % sogar zu einem nierenersatztherapiepflichtigen AKI (Tab. 1 ; [ 13 , 17 , 34 ]).…”
Section: Häufigkeit Von Aki Bei Covid-19 Im Intensivbereichunclassified
“…33–50 % der COVID-19-Patient*innen mit AKI gegenüber 7–8 % der Patient*innen ohne AKI sterben während des Krankenhausaufenthalts [ 10 , 13 ]. Die Mortalität steigt stadienabhängig und ist erwartungsgemäß mit 57–73 % am höchsten bei Patient*innen, die Nierenersatztherapie erhalten [ 17 , 18 , 20 , 34 ]. Zum Vergleich: Die Krankenhausmortalität unter den AOK-Patient*innen, welche invasiv beatmet wurden, jedoch kein Nierenersatzverfahren benötigten, betrug 44,8 % [ 20 ].…”
Section: Verlauf Von Covid-19-assoziiertem Nierenversagen Bei Intensiunclassified
See 1 more Smart Citation